|
Please join us as we celebrate World Hepatitis Day
and the legacy of Dr. Baruch S. Blumberg
| | |
You are cordially invited to join us for two meaningful events this July as we honor the extraordinary legacy of Dr. Baruch S. Blumberg, Nobel Laureate and global health pioneer, and commemorate World Hepatitis Day.
Together these events celebrate the past, present and future of hepatitis B research, public health, and the people who continue this life-saving work.
| |
|
| |
Please join us for the official sign unveiling of the BSBI, the HBF and the PABC as the
Timothy M. Block Research Campus
Monday, July 28, 2025 | 4-6 p.m. EDT
Pennsylvania Biotechnology Center
3805 Old Easton Rd., Doylestown, Pa.
| | | |
|
| |
Please join us for a community forum and public lecture celebrating the Philadelphia roots and global impact of Dr. Blumberg’s work.
Tuesday, July 29, 2025 | 12-3 p.m. EDT [Hybrid]
Benjamin Franklin Hall
American Philosophical Society
427 Chestnut St., Philadelphia
*Registration is required. Hybrid event.
| | | | Watch the recording: B Informed Liver Cancer Patient Conference | | On June 17, 2025, we hosted the B Informed Virtual Liver Cancer Patient Conference—a special event for individuals affected by liver cancer, those living with risk factors like hepatitis B and anyone seeking to learn more. | | |
Attendees heard from patients, healthcare providers and researchers as they shared insights on:
- Liver cancer epidemiology and early detection,
- Navigating the HCC care journey,
- Innovations in diagnosis and treatment,
- Strategies to reduce liver cancer disparities and
- The latest research and community-based solutions.
| | | | If you missed it, it's not too late to be part of the conversation. 👉 View the recording here. Learn more through our Liver Cancer Connect program. | | Join us for the 2025 HBV Community Forum in Berlin or online | | The 2025 Hepatitis B Community Forum will be held as a hybrid event on Sept. 8 in Berlin, Germany, just prior to the opening session of the International HBV Meeting. This unique forum brings together scientists, public health professionals and people living with hepatitis B and D to exchange knowledge, share lived experiences and strengthen collaboration in the fight against HBV. | | |
Let’s work together to fast-track a cure and build a world free from HBV-related stigma.
- Hybrid event
- Attendance is complimentary
| | | | Spotlight on storytelling: Reflections from the April 2025 #justB workshop | | |
At our in-person #justB workshop in Philadelphia last April, five powerful storytellers opened up about their deeply personal experiences with hepatitis B, each offering a unique perspective on resilience, identity and healing. This month, we're featuring three storytellers.
Bruno reflected on his decades-long journey—from an unexpected diagnosis to finding strength in recovery and advocacy. Tay bravely shared their experience navigating hepatitis B alongside body image and identity as a young adult, reminding us that healing is not just physical, but emotional too. Trieu offered a moving account of living silently with hepatitis B before undergoing a life-saving liver transplant—a powerful testament to resilience and the importance of self-advocacy.
| | | | These stories continue to inspire and elevate the voices of those affected by hepatitis B. To explore more powerful and heartfelt journeys, visit our storytelling website at www.hepbstories.org. | | |
Now Available: RNA test for hepatitis delta from LabCorp
We’re pleased to share that LabCorp is now offering an RNA test for hepatitis delta (HDV)—a major step forward in improving access to accurate diagnosis. For years, testing for hepatitis delta was limited and difficult to access. Thanks to recent advancements, reliable testing is now available from several labs across the U.S. and internationally.
| |
Who Should Be Tested?
While the American Association for the Study of Liver Diseases (AASLD) recommends testing only high-risk groups, the Hepatitis B Foundation agrees with the World Health Organization that all individuals living with hepatitis B get tested for hepatitis delta.
Early detection leads to better outcomes. Please talk with your health care provider about getting tested.
| | New Blog | Podcast Recaps: Barriers to hepatitis B programs in prisons | | |
Did you know that people in prison are at much higher risk for hepatitis B—but often lack access to prevention, testing or treatment?
In a recent episode of the B Heppy podcast, researchers Dr. Heidi Emery and Dr. Kathryn Jack from the University of Nottingham discuss the major challenges facing hepatitis B programs in correctional facilities. Based on their research and interviews with incarcerated individuals and prison staff, they shed light on key barriers such as:
- Stigma and lack of hepatitis B awareness,
- Limited healthcare access due to staffing and security issues and
- Inadequate resources and follow-up care after release.
Check out our white paper on HBV in corrections here.
| |
Addressing hepatitis B in prisons isn’t just a justice issue—it’s public health. | Read the full blog and listen to the episode here. | | |
Now live: Global job board for hepatitis B, hepatitis D
and liver cancer research opportunities
| | |
In response to growing interest from the global hepatitis B community, the Hepatitis B Foundation has launched a dedicated job board featuring opportunities in:
Scientific Research, Clinical Studies, Public Health, Policy, Outreach and more.
| Post a job opportunity: Submit your announcement using this brief form. Let’s build the future of liver disease research—one opportunity at a time. Learn more on our website. | | | B Heppy Podcast: Hepatitis B treatments in development | | In this episode, hosts Bright and Anousha are joined by Dr. Nancy Reau of Rush University to explore the latest developments in hepatitis B treatments. | | | | |
Dr. Reau shares expert insights on:
- Promising new therapies in the research pipeline,
- What these treatments could mean for patients and
- How the treatment landscape is evolving.
Whether you're living with hepatitis B, working in the field, or simply want to stay informed—this episode is a must-listen.
| | Seeking youth & adolescent perspectives on hepatitis B | | |
The Hepatitis B Foundation wants to learn about the experiences of young people living with hepatitis B to improve care and support. We are asking all
youth living with hepatitis B to participate in a brief survey. Their insights will help inform clinicians and health care professionals about the unique needs of youth and adolescents. Sign up here.
Questions? Reach out to Catherine.Freeland@hepb.org
| | | Journal article of the month | | |
A call to reclassify the delta hepatitis virus as an orphan disease
Hepatology Communications
July 2025
Click here to access the editorial
Gish RG, Cohen, C, Holden LR, Raymond D, Razavi H, Stiehl L, Thomas DL, Wedemeyer H, Wong RJ Glenn JS, Terrault N
| | | The authors point out in this editorial that now,"...for the first time, there is a robust therapeutic pipeline for this serious disease." They contend: "People living with HDV need better treatment options, and the drug development pipeline needs to be supported to maximize the chance of seeing FDA-approved treatments in the near future. The majority of recent studies to assess the epidemiology of HDV in the United States confirm that while there are pockets of infection that coincide with geographic and demographic risks, overall, the HDV prevalence rates indicate that there are <200,000 HDV-infected people in the United States. Standardization and validation of HDV testing are urgently needed. Until then, the more conservative and reproducible lower prevalence estimates should be used. Thus, the authors believe the Office of Orphan Products Development should use the totality of the data from recent studies and a conservative estimate (1%–5% of patients with HBV) for HDV active infection prevalence in the U.S." | |
We want to hear from YOU
Please take a moment to complete our reader survey and let us know how we’re doing. Your feedback helps us deliver the content that matters most to you. Take the brief survey here.
Thank you for being a valued part of our community!
| | Help us make B News even better. | | | | | Hot off the presses: a novel from a Hepatitis B Foundation co-founder | | |
"Small World, a Novel: The True Story of a Fictional Person's Triumph over Agoraphobia," by Timothy M. Block, PhD, recently was published by Archway Publishing.
It's the first novel by Dr. Block, co-founder of the Hepatitis B Foundation, and he is donating all proceeds from the book to our nonprofit organization.
"This novel, based loosely on a true story, blends the charm and wit of Tom Sawyer and My Family and Other Animals with the profound urgency of Lorenzo’s Oil," the publisher says. Please read more here.
| | | Hepatitis B Foundation now accepts crypto donations | | |
You can now donate cryptocurrency to the Hepatitis B Foundation via The Giving Block! Your crypto gift helps advance research, patient advocacy and global efforts to eliminate hepatitis B—quickly, securely, and with unique tax advantages.
Click here to learn more and make your crypto gift today!
| |
Learn more about our research and education programs at www.hepb.org
| |
The Hepatitis B Foundation is a global nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. Our commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community and the general public. | | | | | | |